190 related articles for article (PubMed ID: 26078788)
1. Differential Expression of ADAM23, CDKN2A (P16), MMP14 and VIM Associated with Giant Cell Tumor of Bone.
Conceição AL; Babeto E; Candido NM; Franco FC; de Campos Zuccari DA; Bonilha JL; Cordeiro JA; Calmon MF; Rahal P
J Cancer; 2015; 6(7):593-603. PubMed ID: 26078788
[TBL] [Abstract][Full Text] [Related]
2. Differentially expressed genes in giant cell tumor of bone.
Babeto E; Conceição AL; Valsechi MC; Peitl Junior P; de Campos Zuccari DA; de Lima LG; Bonilha JL; de Freitas Calmon M; Cordeiro JA; Rahal P
Virchows Arch; 2011 Apr; 458(4):467-76. PubMed ID: 21305317
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic lockdown of CDKN1A (p21) and CDKN2A (p16) characterises the neoplastic spindle cell component of giant cell tumours of bone.
Giesche J; Mellert K; Geißler S; Arndt S; Seeling C; von Baer A; Schultheiss M; Marienfeld R; Möller P; Barth TF
J Pathol; 2022 Aug; 257(5):687-696. PubMed ID: 35522566
[TBL] [Abstract][Full Text] [Related]
4. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
Han YX; Liang DY
Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone.
Mosakhani N; Pazzaglia L; Benassi MS; Borze I; Quattrini I; Picci P; Knuutila S
Histol Histopathol; 2013 May; 28(5):671-8. PubMed ID: 23172052
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Transcriptome Profiling of the Neoplastic Giant Cell Tumor of Bone Stromal Cells by RNA Sequencing.
Lau CP; Kwok JS; Tsui JC; Huang L; Yang KY; Tsui SK; Kumta SM
J Cell Biochem; 2017 Jun; 118(6):1349-1360. PubMed ID: 27862217
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
8. Expression of ezrin, CD44, and VEGF in giant cell tumor of bone and its significance.
Zhang J; Dong J; Yang Z; Ma X; Zhang J; Li M; Chen Y; Ding Y; Li K; Zhang Z
World J Surg Oncol; 2015 May; 13():168. PubMed ID: 25929323
[TBL] [Abstract][Full Text] [Related]
9. Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.
Mukaihara K; Suehara Y; Kohsaka S; Akaike K; Tanabe Y; Kubota D; Ishii M; Fujimura T; Kazuno S; Okubo T; Takagi T; Yao T; Kaneko K; Saito T
PLoS One; 2016; 11(2):e0148401. PubMed ID: 26863138
[TBL] [Abstract][Full Text] [Related]
10. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer.
Calmon MF; Colombo J; Carvalho F; Souza FP; Filho JF; Fukuyama EE; Camargo AA; Caballero OL; Tajara EH; Cordeiro JA; Rahal P
Cancer Genet Cytogenet; 2007 Feb; 173(1):31-7. PubMed ID: 17284367
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T
PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380
[TBL] [Abstract][Full Text] [Related]
12. p62 overexpression promotes neoplastic stromal cell proliferation and is associated with the recurrence of giant cell tumor of bone.
Liu S; Ye F; Li D; He C; He H; Zhang J
Oncol Lett; 2020 Oct; 20(4):86. PubMed ID: 32863919
[TBL] [Abstract][Full Text] [Related]
13. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
Branstetter DG; Nelson SD; Manivel JC; Blay JY; Chawla S; Thomas DM; Jun S; Jacobs I
Clin Cancer Res; 2012 Aug; 18(16):4415-24. PubMed ID: 22711702
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
15. ALCAM
Zhou Z; Li Y; Wang X; Hu J; Kuang M; Wang Z; Li S; Xu W; Xiao J
Cell Death Dis; 2018 Feb; 9(3):299. PubMed ID: 29463803
[TBL] [Abstract][Full Text] [Related]
16. Cytokines expressed in multinucleated cells: Paget's disease and giant cell tumors versus normal bone.
Mills BG; Frausto A
Calcif Tissue Int; 1997 Jul; 61(1):16-21. PubMed ID: 9192505
[TBL] [Abstract][Full Text] [Related]
17. CD10 and CD138 can be expressed in giant cell tumor of bone: An immunohistochemical study.
Al-Abbadi MA; Al-Yousef MJ; Yousef MM; Sheikh SS; Almasri NM; Amr SS
Avicenna J Med; 2016; 6(3):69-74. PubMed ID: 27390668
[TBL] [Abstract][Full Text] [Related]
18. Rapidly growing giant cell tumor of bone in a skeletally immature girl.
Akaike G; Ueno T; Matsumoto S; Motoi N; Matsueda K
Skeletal Radiol; 2016 Apr; 45(4):567-73. PubMed ID: 26585568
[TBL] [Abstract][Full Text] [Related]
19. Biological characteristics of a novel giant cell tumor cell line derived from spine.
Zhou Z; Li Y; Xu L; Wang X; Chen S; Yang C; Xiao J
Tumour Biol; 2016 Jul; 37(7):9681-9. PubMed ID: 26801673
[TBL] [Abstract][Full Text] [Related]
20. Population-based study of giant cell tumor of bone in Sweden (1983-2011).
Amelio JM; Rockberg J; Hernandez RK; Sobocki P; Stryker S; Bach BA; Engellau J; Liede A
Cancer Epidemiol; 2016 Jun; 42():82-9. PubMed ID: 27060625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
